---

Market Overview

---

The US pharmaceutical packaging market had a valuation of $28.33 billion in 2022 and is projected to reach $36.58 billion by 2028, exhibiting a compound annual growth rate (CAGR) of 4.35% during the study period.

Pharmaceutical packaging plays a crucial role in the packaging process of pharmaceutical preparations. It includes tasks such as dosing, dispensing, and facilitating the use of pharmaceutical products. The primary objective of packaging is to ensure the safety and integrity of the drugs, with one important aspect being the selection of materials that do not react with the packaged drugs.

The market in the United States is experiencing significant growth, driven by factors such as the increasing demand for prescription drugs, the presence of leading pharmaceutical players, well-developed infrastructure, high investments in drug development, and a high per capita income. Among all the product groups in pharmaceutical packaging, parenteral containers have witnessed the fastest growth in demand. This can be attributed to advancements in biotechnology, which have led to the introduction of new injectable therapies.

---

Market Segmentation

---

The market is segmented based on various factors, including packaging type, primary packaging type, material type, and end-user type.

Segmentation by Packaging Type
Primary
Secondary
Tertiary

Segmentation by Primary Packaging Type
Ampoules
Vials
Blisters & Strip
Bottles & Jars
Containers & Tubes
Pouches & Sachets
Others

Segmentation by Material Type
Paper
Glass
Plastic
Others

Segmentation by End-user Type
Pharmaceuticals & Biotech Companies
CMOs/CDMOs
Others

In 2022, the United States held a significant market share in the North American pharmaceutical packaging market. This can be attributed to several factors, including the increasing demand for prescription drugs, the presence of leading pharmaceutical players, well-developed infrastructure, high investments in drug development, and high per capita income.

Within the US pharmaceutical packaging market, primary packaging accounted for over 70% of the market share. This is due to the growing demand for blister packs, bottles, vials, ampoules, pouches, sachets, and bags, aligned with the increasing demand for pharmaceutical products.

Among primary packaging types, the strips and blister packaging segment accounted for a market share of 33.50% in the US pharmaceutical packaging market. This segment dominated others due to its extensive use as a crucial primary packaging component for pharmaceutical products.

In terms of material types, the paper segment holds a market share of 38.92% in the US pharmaceutical packaging market. This can be attributed to its high demand in secondary and tertiary packaging and the increasing need for recyclable materials.

Pharmaceutical and biotech companies accounted for the highest share of over 46% in the US pharmaceutical packaging market. This can be attributed to factors such as the growing aging population, increasing demand for branded drugs, over-the-counter drugs, and specialty medicines, patent expirations of drugs, and higher drug prices.

---

Competitive Landscape

---

The market presents immense growth prospects for both current and future/emerging players due to advancements in the treatment of oncology, autoimmune diseases, diabetes, chronic illnesses, and rare diseases.

Key companies profiled in this report include Amcor, Aptar Group, Berry Global, Gerresheimers AG, WestRock Pharmaceuticals, ACG, Airnov, Becton, Dickinson and company (BD), Bilcare Research, Borosil, CCL, Drug Plastics Group, DWK Life Sciences, LOG, Meghmani Group, Nolato, Nemera, PolyCine, Renolit, Specialty Polyfilms, Vetter, West Pharmaceuticals, Wihuri Group, Comar, Constantia, Kp, Nipro, Medical Packaging Inc, Bandall.